Saturna Capital Corp Abbott Laboratories Transaction History

Saturna Capital Corp

  • $6.54 Billion
  • Q1 2025

A detailed history of Saturna Capital Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Saturna Capital Corp holds 393,320 shares of ABT stock, worth $52.9 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
393,320
Previous 394,195 0.22%
Holding current value
$52.9 Million
Previous $44.6 Million 17.01%
% of portfolio
0.8%
Previous 0.62%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 02, 2025
SELL
$111.1 - $140.22 $97,212 - $122,692
-875 Reduced 0.22%
393,320 $52.2 Million
Q4 2024

Feb 07, 2025
BUY
$111.93 - $119.39 $13,879 - $14,804
124 Added 0.03%
394,195 $44.6 Million
Q3 2024

Nov 05, 2024
SELL
$100.07 - $118.13 $1.3 Million - $1.54 Million
-13,033 Reduced 3.2%
394,071 $44.9 Million
Q2 2024

Jul 31, 2024
SELL
$100.73 - $112.44 $1.71 Million - $1.91 Million
-16,994 Reduced 4.01%
407,104 $42.3 Million
Q1 2024

May 13, 2024
SELL
$109.52 - $120.96 $308,846 - $341,107
-2,820 Reduced 0.66%
424,098 $48.2 Million
Q4 2023

Feb 06, 2024
SELL
$90.19 - $110.4 $520,666 - $637,339
-5,773 Reduced 1.33%
426,918 $47 Million
Q3 2023

Nov 14, 2023
SELL
$95.53 - $114.62 $370,178 - $444,152
-3,875 Reduced 0.89%
432,691 $41.9 Million
Q2 2023

Aug 04, 2023
BUY
$100.78 - $112.29 $287,726 - $320,587
2,855 Added 0.66%
436,566 $47.6 Million
Q1 2023

May 15, 2023
BUY
$96.86 - $114.01 $86,495 - $101,810
893 Added 0.21%
433,711 $43.9 Million
Q4 2022

Feb 09, 2023
SELL
$95.06 - $111.52 $508,761 - $596,855
-5,352 Reduced 1.22%
432,818 $47.5 Million
Q3 2022

Nov 10, 2022
SELL
$96.76 - $112.03 $29,028 - $33,609
-300 Reduced 0.07%
438,170 $42.4 Million
Q2 2022

Aug 12, 2022
SELL
$102.07 - $123.37 $72,571 - $87,716
-711 Reduced 0.16%
438,470 $47.6 Million
Q1 2022

May 10, 2022
BUY
$114.02 - $139.04 $222,224 - $270,988
1,949 Added 0.45%
439,181 $52 Million
Q4 2021

Feb 09, 2022
BUY
$115.53 - $141.46 $21,835 - $26,735
189 Added 0.04%
437,232 $59.6 Million
Q3 2021

Nov 08, 2021
BUY
$116.66 - $129.06 $273,801 - $302,903
2,347 Added 0.54%
437,043 $51.6 Million
Q2 2021

Aug 11, 2021
BUY
$105.79 - $124.53 $204,174 - $240,342
1,930 Added 0.45%
434,696 $50.4 Million
Q1 2021

May 14, 2021
BUY
$108.84 - $128.23 $346,437 - $408,156
3,183 Added 0.74%
432,766 $51.9 Million
Q4 2020

Feb 12, 2021
SELL
$105.0 - $114.42 $1,050 - $1,144
-10 Reduced -0.0%
429,583 $47 Million
Q3 2020

Nov 10, 2020
BUY
$91.64 - $111.29 $42,887 - $52,083
468 Added 0.11%
429,593 $46.8 Million
Q1 2020

May 14, 2020
BUY
$62.82 - $91.86 $6,282 - $9,186
100 Added 0.02%
429,125 $33.9 Million
Q3 2019

Nov 14, 2019
SELL
$81.84 - $88.74 $24,552 - $26,622
-300 Reduced 0.07%
429,025 $35.9 Million
Q2 2019

Jul 31, 2019
BUY
$72.88 - $85.0 $18,001 - $20,995
247 Added 0.06%
429,325 $36.1 Million
Q1 2019

May 15, 2019
SELL
$66.22 - $80.06 $303,420 - $366,834
-4,582 Reduced 1.06%
429,078 $34.3 Million
Q4 2018

Feb 08, 2019
SELL
$65.56 - $74.27 $19,668 - $22,281
-300 Reduced 0.07%
433,660 $31.4 Million
Q2 2018

Aug 02, 2018
SELL
$57.57 - $63.54 $43,925 - $48,481
-763 Reduced 0.18%
433,960 $26.5 Million
Q1 2018

May 10, 2018
SELL
$56.27 - $63.62 $119,798 - $135,446
-2,129 Reduced 0.49%
434,723 $26 Million
Q4 2017

Feb 06, 2018
BUY
$53.68 - $57.47 $45,091 - $48,274
840 Added 0.19%
436,852 $24.9 Million
Q3 2017

Nov 14, 2017
SELL
$48.06 - $53.64 $9,804 - $10,942
-204 Reduced 0.05%
436,012 $23.3 Million
Q2 2017

Aug 14, 2017
BUY
N/A
436,216
436,216 $21.2 Million

Others Institutions Holding ABT

# of Institutions
3,600
Shares Held
1.4B
Call Options Held
9.23M
Put Options Held
8.1M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $236B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email